Winship Invest$ Pilot Grant Program
Winship Invest$ is a peer-reviewed program that provides pilot funding for novel, innovative cancer research projects. With two funding opportunities a year, the program enables Winship investigators to obtain preliminary data and results for publication and for subsequent peer-reviewed funding applications. Successful applications are supported by philanthropic contributions to Winship and by developmental funds from Winship’s NCI Cancer Center Support Grant.
The current cycle seeks applications in the following research domains: (1) Winship's Four Research Programs; (2) Promoting Cancer Health Equity and Reducing Cancer Disparities; (3) Joint Winship and Biomedical Engineering Focused Research Projects; and (4) Breast Cancer.
Eligibility criteria include the following:
- Pilot projects will be awarded to active Winship members.
- Proposals with a budget of up to $50,000 for one year may be considered for Winship Invest$ (unless otherwise stated for specific research domains).
- Investigators may submit only one Winship Invest$ proposal per funding cycle.
- Salary support for the principal investigator is not allowed except for junior faculty at the rank of Assistant Professor and below.
- For additional eligibility criteria and application requirements, please refer to the Request for Proposals.
RFP Announcement: August 9, 2023
Letter of Intent Receipt Date: Wednesday, August 30, 2023
Application Receipt Date: Friday, September 29, 2023
Anticipated Start Date: January 1, 2024
NCI R50 Research Specialist (Clinician Scientist) AwardWinship Cancer Institute is seeking nominations for an NCI R50 Research Specialist, an opportunity intended specifically for clinician scientists and designed to encourage the development of a career path for cancer clinical trial investigators who provide leadership, participation and scientific support for the NCI clinical trials networks.
Eligibility requirements include the following:
- Clinical degree (M.D., D.O., D.D.S., D.M.D., O.D., D.C., PharmD., N.D., D.V.M.)
- Must possess active licensure and is actively practicing in an oncology clinical setting
- Individuals with a Ph.D. or other doctoral degree that have direct contact with patients or healthy subjects in clinical disciplines such as clinical psychology, nursing, clinical genetics, speech-language pathology, audiology, or rehabilitation are also eligible.
- At the time of application, the applicant cannot hold as a Principal Investigator on current R01, P01, or other significant NIH funding (past funding does not affect eligibility).
- The applicant must currently be engaged in the conduct of NCI-funded cancer clinical trials research at Winship and have a record of involvement in NCI-funded cancer clinical trial-related activities.
- At the time of application, the applicant must have a full-time position and have been at Emory University for at least the previous two years.
Internal Competition Guidelines
The NCI R50 Research Specialist funding opportunity limits applications to one new (A0) and one resubmission (A1) per institution per receipt date. Interested applicants should submit the PI’s CV or NIH-formatted biosketch and a Letter of Intent that identifies the PI and addresses the eligibility requirements listed above. The selected investigator will be notified and invited to submit a full application by Winship.
Letters of Intent for the next review cycle (Cycle 2) are due on or before 11:59 pm, Saturday, April 1, 2023, and should be submitted to: email@example.com. Please direct any questions you have regarding this funding opportunity to firstname.lastname@example.org or Dana Ray via email or at (404) 778-5137.
RFP Announcement: Wednesday, March 1, 2023
Letter of Intent: 11:59 pm, Saturday, April 1, 2023
Winship Announcement of Nominee Selection: Monday, April 10, 2023
Application Receipt Date: Tuesday, June 6, 2023
Anticipated Start Date: April 2024
The Donaldson Charitable Trust Research Synergy Fund
Winship Cancer Institute, in collaboration with the Aflac Cancer & Blood Disorders Center at Children’s Healthcare of Atlanta and the Wallace H. Coulter Biomedical Engineering Department at Emory University and the Georgia Institute of Technology, is releasing a 2022 Request for Pilot Grant Proposals (RFP) supported by The Donaldson Charitable Trust Research Synergy Fund. This peer-reviewed program provides pilot funding for novel, innovative, and collaborative cancer research projects.
Proposals with a budget of up to $125,000 for one year will be considered for funding by The Donaldson Charitable Trust Research Synergy Fund. Applications should reflect collaborative team science projects that must include at least 2 of the 3 partnering units (i.e., Winship, Aflac, BME).
See RFP for eligibility criteria.
Letters of Intent should be uploaded as a single document to https://intranet.winship.emory.edu/pilotgrant no later than 5:00pm on Friday, December 2nd, 2022.
RFP Announcement: November 11, 2022
Letter of Intent: December 2, 2022
Application Receipt date: January 4, 2023
Awardee Announcement: February 8, 2023
Anticipated Start date: March 1, 2023
Please direct any questions you have regarding this funding opportunity to WinshipGrants@emory.edu.
Winship-UGA Collaborative Pilot GrantsWinship Cancer Institute and the University of Georgia Cancer Center have partnered to support a peer-reviewed program that provides pilot funding for novel, innovative cancer research projects. This program aims to enable faculty collaborators from both institutions to launch new, promising lines of research that focus on exploring the strengths and synergies of the two institutions. Collaborations should seek to share knowledge and develop partnerships that deliver impact for the state of Georgia and beyond. The maximum budget for each project is $50,000 for one year ($25,000 per institute).
- Independent investigators at the Assistant Professor level or above at either Emory with a Winship membership or the University of Georgia with a faculty rank in either institution.
- Submission is limited to one proposal per collaborative team.
- Proposals must include at least one investigator from each institution (UGA and Winship).
- Funding opportunity is not intended to support for an ongoing research project.
- Awardees are expected to submit an application for external grant support within 1 year of completion of project.
Letter of Intent Receipt Date: September 15, 2023
Applicants Notified to Proceed with Full Proposal: September 22, 2023
Application Receipt Date: October 23, 2023
Anticipated Start Date: January 1, 2024
Letters of Intent are due no later than 11:59 pm on Friday, September 15, 2023 and should be submitted as a single pdf by the Winship Contact PI to email@example.com. Please direct any questions you have regarding this funding opportunity to firstname.lastname@example.org.
American Cancer Society Institutional Research Grant
Winship's American Cancer Society Institutional Research Grant (ACS-IRG) supports the early development of junior faculty in their independent cancer research careers through an annual call for pilot projects, providing a mechanism to test ideas and obtain preliminary results that will ultimately position them to successfully compete for national peer-reviewed funding.
The program solicits innovative pilot projects in clinical, basic, or translational cancer-related research that offer significant potential for reducing the incidence, mortality, and morbidity of cancer and/or improving quality of life. ACS initiatives also focus on the fields of cancer prevention and cancer control and eliminating cancer disparities.
As part of the ACS Diversity, Equity, and Inclusion strategy, they are creating new initiatives for increasing diversity in cancer research. This supplemental funding is targeted for an underrepresented minority investigator in the amount of $40,000.
Letter of Intent: Friday, October 20, 2023
Selection for Full Proposal: Monday, October 23, 2023
Full Application Receipt Date: Monday, November 20, 2023
Pilot Project Start Date: January 1, 2024
For more information including eligibility criteria, visit the ACS Institutional Research Grant web page.
Please direct any questions you have regarding this funding opportunity to Venus Henriques (email@example.com).
V Foundation Clinical Scholar Program
To accelerate cancer treatment and cures, the V Foundation’s Clinical Scholar program proposes to develop the careers of clinicians who will become leaders in developing programs of clinical trials that are sequential and based on hypothesis-driven research. The total grant amount is $200,000, paid in two annual installments of $100,000. Only direct costs of the research are supported by this award (no indirects allowed). The V Foundation allows flexibility in how the PI can use these funds (e.g., salary, protected time, program costs and some correlates), but it is insufficient to fund the major costs of a clinical trial.
Letters of Intent (not to exceed 2 pages) are due Monday, March 7, 2022 via email to firstname.lastname@example.org. Letters of Intent should also include the PI’s NIH Biosketch, a proposed title for the research project, and a brief 1-2 page abstract of the proposed research project. The selected investigator will be notified and invited to submit a full application by Winship.
- Applicants must be nominated by their Cancer Center Director or similar high ranking research official.
- Applicants must be clinicians (at minimum, Assistant Professor for at least 3 years) and have experience leading clinical trials, but not yet achieved the level of Full Professor.
- Applicants must be board-certified (if applicable to their discipline; certification received within 7 years) or board-eligible in (for example, but not limited to) surgical oncology, gynecologic oncology, medical oncology, radiation oncology, pediatric oncology, or internal medicine. Other oncology disciplines that are not listed may be included and, in some cases, may not require board certification, depending on the discipline.
- The Department Chair and Division Head must support the applicant’s plans for career development and commit to long-term support of the applicant.
Date of RFP Announcement: February 16, 2022
Winship Letter of Intent Due Date: March 7, 2022
Winship Announcement of Nominee Selection: March 14, 2022
Nomination Due Date (to V Foundation): March 15, 2022
V Foundation Application Due Date: April 13, 2022 by 5:00 pm ET
Please direct any questions you have regarding this funding opportunity to email@example.com.
Winship Catalyst Fund
The Winship Catalyst Fund supports the pre-clinical development of novel treatment approaches for cancer therapy, diagnostics, or prevention. The novel approach should be based on a scientific discovery made by the applicant and poised for rapid pre-clinical work with the ultimate objective of seeking an Investigational New Drug (IND) application from the FDA.
Proposals with a budget of up to $250,000 for year one may be considered subject to meeting milestones. Project(s) selected for funding will have an option of up to $1,000,000 in total funding if the project makes the necessary progress to launch a future clinical trial or seek an IND.
Letters of Intent should be uploaded to https://intranet.winship.emory.edu/pilotgrant no later than 5 p.m. on Monday, February 28, 2022.
RFP Announcement: February 16, 2022
Letter of Intent: February 28, 2022
Application Receipt Date: March 28, 2022
Anticipated Start Date: June 1, 2022
Please direct any questions you have regarding this funding opportunity to firstname.lastname@example.org.
Elkin Fellowship and Rochfort Scholarship
Winship is pleased to announce the annual call for two awards that support extraordinary physician-scientists who have career goals in the research and treatment or prevention of cancer.
The Nell W. and William S. Elkin Fellowship in Oncology is to assist an extraordinary scientist and clinician with career goals in the research and treatment of cancer. Scholarships are $35,000 for one year and are intended to help cover partial salary, laboratory or other research expenses or travel. A discretionary account will be set up for use by the recipient’s department.
The Chester P. Rochfort Scholarship in Oncology is to assist young MD degree holders in cancer research. The scholarship is $10,000 for one year and intended to help cover partial salary, laboratory or other research expenses or travel. A discretionary account will be set up for use by the recipient’s department.
Completed applications should be uploaded as a single document to https://intranet.winship.emory.edu/pilotgrant no later than 11:59 pm on Monday, May 22, 2023.
To be eligible for this award mechanism, the applicant must meet the following criteria:
- Physician (MD, MD/PhD) with enrollment within the Emory University School of Medicine or Rollins School of Public Health Fellowship Programs
- Awardee must be in an oncology field with career goals in the research and treatment/prevention of cancer.
Application Deadline: Monday, May 22, 2023
Announcement of Awardees: Monday, June 12, 2023
Anticipated Start Date: Wednesday, July 5, 2023
Please direct any questions you have regarding these funding opportunities to Kadiatou Fofana via email.
Winship Invest$ Prostate Cancer Research Pilot Grant
Thanks to generous gifts from the Senior Men’s Golf Association of Dunwoody Country Club and the Club’s John Kauffman Prostate Cancer Golf Event, Winship Cancer Institute is pleased to announce a prostate cancer research pilot grant opportunity for Winship members. Innovative proposals that address prostate cancer research including but not limited to basic or translational research, investigator initiated clinical trials (related IRB submission must be either in review or approved), health disparities, imaging, survivorship or quality of life will be considered for funding.
The Spring 2021 application process is now closed.
Winship Lung Cancer SPORE pilot grants
The Winship Lung Cancer Specialized Program of Research Excellence (SPORE) offers two pilot grants of up to $50,000 each to support projects focused on career enhancement or developmental research in the area of lung cancer. The Career Enhancement Program aims to promote the advancement of early career lung cancer investigators. The Developmental Research Program aims to identify new and innovative research opportunities by supporting meritorious proposals that could expand into future research projects in the future.
The application process for the 2023 cycle is now open.
Winship 5K Endowed Professorship in Cancer Research
The Annual Winship 5K Endowed Professorship in Cancer Research provides special recognition to a faculty member for continuing exemplary service in the field of cancer research both at the institutional and national level. The professorship is supported by funds raised through the annual Winship Win the Fight 5K.
The nomination and application process is now closed.